Back to search
FDAFDA · Food and drugs·Recall number D-1407-2014

Gemcitabine For Injection USP, 1 g, (lyophilized), For Intravenous Use Only, Sterile Single Use Vial, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd, Gujarat, India, NDC 47335-154-40

Published July 2, 2014 · Recall initiated: April 9, 2014

Summary

FDA records drug Class II recall D-1407-2014, published July 2, 2014 and initiated April 9, 2014. Recalling firm: Caraco Pharmaceutical Laboratories, Ltd.; Status: Terminated; Reported quantity: 200 vials; Lot: JKM7188A. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: A particle excursion for a different batch of the same product may lead to a lack of sterility assurance.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Caraco Pharmaceutical Laboratories, Ltd.
Distributor
OH
Lot
JKM7188A
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Gemcitabine For Injection USP, 1 g, (lyophilized), For Intravenous Use Only, Sterile Single Use Vial, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd, Gujarat, India, NDC 47335-154-40 recalled?

Yes. FDA published recall D-1407-2014 on July 2, 2014. Reported hazard: Lack of Assurance of Sterility: A particle excursion for a different batch of the same product may lead to a lack of sterility assurance.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone